These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 35232428)
1. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma. Liu C; Liu Y; Yu Y; Zhao Y; Yu A BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma. Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients. Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma. Guo S; Chen J; Yi X; Lu Z; Guo W Front Immunol; 2022; 13():985051. PubMed ID: 36248853 [TBL] [Abstract][Full Text] [Related]
5. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma. Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J Front Immunol; 2022; 13():922315. PubMed ID: 35774794 [TBL] [Abstract][Full Text] [Related]
7. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients. Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753 [TBL] [Abstract][Full Text] [Related]
8. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma. Hong Y; Lin M; Ou D; Huang Z; Shen P BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531 [TBL] [Abstract][Full Text] [Related]
9. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848 [TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-related genes are candidate diagnostic and prognostic biomarkers for skin cutaneous melanoma. Jing HY; Gu W; Tan XY; Ma YR Biomark Med; 2022 Feb; 16(3):179-196. PubMed ID: 35057634 [TBL] [Abstract][Full Text] [Related]
11. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma. Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y Front Surg; 2022; 9():860806. PubMed ID: 35937602 [TBL] [Abstract][Full Text] [Related]
12. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma. Zhou J; Wang X; Li Z; Jiang R FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature. Chen Y; Guo L; Zhou Z; An R; Wang J BMC Genomics; 2022 Mar; 23(1):245. PubMed ID: 35354376 [TBL] [Abstract][Full Text] [Related]
14. Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma. Du X; Zhang Y Front Genet; 2020; 11():614888. PubMed ID: 33391356 [TBL] [Abstract][Full Text] [Related]
15. A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer. Qi X; Wang R; Lin Y; Yan D; Zuo J; Chen J; Shen B Front Genet; 2021; 12():692426. PubMed ID: 34276794 [TBL] [Abstract][Full Text] [Related]
16. Multi Wu M; Li K; Liao Y; Li L; Xiao X; Chen Y; Guo J; Hu F; Qu J; Wang Z; Feng H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):159-174. PubMed ID: 38755712 [TBL] [Abstract][Full Text] [Related]
17. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients. Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038 [TBL] [Abstract][Full Text] [Related]
18. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis. Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454 [TBL] [Abstract][Full Text] [Related]
19. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer. Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y Front Oncol; 2021; 11():686044. PubMed ID: 34422642 [TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma. Guo W; Wang X; Wang Y; Zhu S; Zhu R; Zhu L Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]